StonvexLoading…
StonvexStonvexStonvexCore line items from SARO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.06B | $5.24B | $4.56B | $4.15B |
Operating Income | $551.07M | $403.22M | $337.36M | $262.63M |
Net Income | $277.42M | $10.97M | $-35.06M | $-21.00M |
EPS (Diluted) | $0.83 | $0.04 | $-0.13 | $-0.08 |
Total Assets | $6.56B | $6.21B | $5.76B | Not available |
Total Liabilities | $3.89B | $3.84B | $4.61B | Not available |
Cash & Equivalents | $289.72M | $102.58M | $57.98M | $120.06M |
Free Cash Flow OCF − CapEx | $234.30M | $-26.61M | $12.76M | $-13.98M |
Shares Outstanding | 334.29M | 334.46M | 281.21M | 275.18M |